Commentary/Editorials

Immunogenicity of cell death driven by immune effectors
Lorenzo Galluzzi, Giulia Petroni, Guido Kroemer

Journal for ImmunoTherapy of Cancer Apr 2020, 8 (1) e000802; DOI: 10.1136/jitc-2020-000802
Repurposing infectious disease vaccines for intratumoral immunotherapy
Ignacio Melero, Maria Gato, Tala Shekarian, Angela Aznar, Sandrine Valsesia-Wittmann, Christophe Caux, Iñaki Etxeberrria, Alvaro Teijeira, Aurelien Marabelle

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000443; DOI: 10.1136/jitc-2019-000443
Management of hepatitis B in the era of checkpoint inhibition
Janice Dutcher

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000276; DOI: 10.1136/jitc-2019-000276
Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
Esther Lutgens, Tom T.P. Seijkens

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000300; DOI: 10.1136/jitc-2019-000300
Moving cancer immunotherapy forward through the Journal for ImmunoTherapy of Cancer (JITC)
Pedro Romero

Journal for ImmunoTherapy of Cancer Jan 2020, 8 (1) e000001; DOI: 10.1136/jitc-2019-000001
Being “penny-wise but pound foolish” in cancer immunotherapy research: the urgent need for mouse cancer models to reflect human modifying factors
William J. Murphy

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 88; DOI: 10.1186/s40425-016-0195-0
A quantum leap in cancer vaccines?
Eli Gilboa

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 87; DOI: 10.1186/s40425-016-0192-3
Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients by Halama et al
Dustin A. Deming

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 93; DOI: 10.1186/s40425-016-0197-y
TCR diversity – a universal cancer immunotherapy biomarker?
Douglas G. McNeel

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 69; DOI: 10.1186/s40425-016-0175-4
Application of the Immunoscore as prognostic tool for hepatocellular carcinoma
Annacarmen Petrizzo, Luigi Buonaguro

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 71; DOI: 10.1186/s40425-016-0182-5

Main menu

Commentary/Editorials

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Commentary/Editorials

Pages